Skip to content
Open access · OA via Europe PMC

Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.

David Sarmento C, Drouard G, Saari TT, Aaltonen A, Heikkinen A, Hukkanen M, Palviainen T, Herukka SK, Kokkola T, Kärkkäinen S, FinnGen, Palotie A, Julkunen V, Runz H, Kaprio J

Alzheimer's & dementia (Amsterdam, Netherlands) · 2026 · ▲ 1 citations

Abstract

<h4>Introduction</h4>Proteomic aging clocks detect disease-related systemic and organ-specific changes and are easily accessible by minimally invasive blood draws. However, their potential in Alzheimer's disease (AD) assessment remains unestablished.<h4>Methods</h4>We investigated associations of proteomic and epigenetic clocks with AD-related blood-based biomarkers and cognitive tests. Omics were generated from blood samples of 153 cognitively unimpaired individuals (average age 62 years); blood biomarkers and cognition were measured approximately nine years after.<h4>Results</h4>Proteomic clocks explained up to 23% of variance in cognitive and biomarker measures not explained by epigenetics. Accelerated systemic and brain-specific proteomic aging were linked to poorer cognition and higher levels of plasma neurofilament light chain. Exploratory interaction analyses suggested weaker proteomic aging-cognition associations in individuals with higher genetic liability for diabetes.<h4>Discussion</h4>Our study illustrates the potential of plasma proteomic clocks in detecting AD-related phenotypes. However, co-morbidities possibly constitute confounding factors, compromising the performance of proteomic aging models.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1002/dad2.70456
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
C, D.S., G, D., TT, S., A, A., A, H., M, H., T, P., SK, H., T, K., S, K., FinnGen, A, P., V, J., H, R., J, K., M, O., &amp; E., V. (2026). Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis. <em>Alzheimer's & dementia (Amsterdam, Netherlands)</em>. https://doi.org/10.1002/dad2.70456
Vancouver
C DS, G D, TT S, A A, A H, M H, et al. Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis. Alzheimer's & dementia (Amsterdam, Netherlands). 2026. doi:10.1002/dad2.70456.
BibTeX
@article{david2026Associ, title = {Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.}, author = {David Sarmento C and Drouard G and Saari TT and Aaltonen A and Heikkinen A and Hukkanen M and Palviainen T and Herukka SK and Kokkola T and Kärkkäinen S and FinnGen and Palotie A and Julkunen V and Runz H and Kaprio J and Ollikainen M and Vuoksimaa E.}, journal = {Alzheimer's & dementia (Amsterdam, Netherlands)}, year = {2026}, doi = {10.1002/dad2.70456}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings